An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)
Age: 18 - 75 years
Gender: All
We've found 1 total result for "Liver Cirrhosis Biliary".
We've found 1 total result for "Liver Cirrhosis Biliary".
An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)
Age: 18 - 75 years
Gender: All